453 related articles for article (PubMed ID: 35157072)
1. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
[TBL] [Abstract][Full Text] [Related]
2. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
3. Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.
Staerk C; Wistuba T; Mayr A
BMC Public Health; 2021 Jun; 21(1):1073. PubMed ID: 34090392
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
5. Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study.
Cai R; Novosad P; Tandel V; Asher S; Malani A
BMJ Open; 2021 Oct; 11(10):e050920. PubMed ID: 34610940
[TBL] [Abstract][Full Text] [Related]
6. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
7. [Infection fatality rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].
Zejda JE; Kowalska M; Brożek GM; Barański K; Kaleta-Pilarska A
Med Pr; 2021 Dec; 72(6):671-676. PubMed ID: 34751682
[TBL] [Abstract][Full Text] [Related]
8. Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020.
Vivian Thangaraj JW; Kumar MS; Velusamy S; Girish Kumar CP; Selvaraju S; Sabarinathan R; Jagadeesan M; Hemalatha MS; Bhatnagar T; Murhekar MV
Indian J Med Res; 2021 May; 153(5&6):546-549. PubMed ID: 34528527
[TBL] [Abstract][Full Text] [Related]
9. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
10. Age-specific SARS-CoV-2 infection fatality rates derived from serological data vary with income and income inequality.
Rickards CG; Kilpatrick AM
PLoS One; 2023; 18(5):e0285612. PubMed ID: 37196049
[TBL] [Abstract][Full Text] [Related]
11. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
12. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
13. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors.
Pedersen OB; Nissen J; Dinh KM; Schwinn M; Kaspersen KA; Boldsen JK; Didriksen M; Dowsett J; Sørensen E; Thørner LW; Larsen MAH; Grum-Schwensen B; Sækmose S; Paulsen IW; Frisk NLS; Brodersen T; Vestergaard LS; Rostgaard K; Mølbak K; Skov RL; Erikstrup C; Ullum H; Hjalgrim H
Clin Infect Dis; 2021 Nov; 73(9):e2962-e2969. PubMed ID: 33103182
[TBL] [Abstract][Full Text] [Related]
15. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.
Wagner R; Peterhoff D; Beileke S; Günther F; Berr M; Einhauser S; Schütz A; Niller HH; Steininger P; Knöll A; Tenbusch M; Maier C; Korn K; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200766
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.
Meyerowitz-Katz G; Merone L
Int J Infect Dis; 2020 Dec; 101():138-148. PubMed ID: 33007452
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
[TBL] [Abstract][Full Text] [Related]
18. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
[TBL] [Abstract][Full Text] [Related]
19. Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.
Kaspersen KA; Hindhede L; Boldsen JK; Mikkelsen S; Vestergaard LS; Berthelsen AN; Moustsen-Helms IR; Holm DK; Nilsson AC; Sækmose SG; Sørensen E; Harritshøj LH; Aagaard B; Hjalgrim H; Lillevang ST; Jørgensen CS; Krause TG; Ullum H; Pedersen OBV; Ostrowski SR; Erikstrup C
J Infect Dis; 2022 Jan; 225(2):219-228. PubMed ID: 34788834
[TBL] [Abstract][Full Text] [Related]
20. High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
Ngere I; Dawa J; Hunsperger E; Otieno N; Masika M; Amoth P; Makayotto L; Nasimiyu C; Gunn BM; Nyawanda B; Oluga O; Ngunu C; Mirieri H; Gachohi J; Marwanga D; Munywoki PK; Odhiambo D; Alando MD; Breiman RF; Anzala O; Njenga MK; Bulterys M; Herman-Roloff A; Osoro E
Int J Infect Dis; 2021 Nov; 112():25-34. PubMed ID: 34481966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
